Loading company
PTC THERAPEUTICS, INC. (PTCT) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $1.7 billion | $806.8 million | +114.5% | 10-K 2026-02-19 · proof |
| Operating income | $866.9 million | -$302.6 million | 10-K 2026-02-19 · proof | |
| Net income | $682.6 million | -$363.3 million | 10-K 2026-02-19 · proof | |
| Cash from operating activities | $711.2 million | -$107.7 million | 10-K 2026-02-19 · proof | |
| Free cash flow | $702.3 million | -$114.2 million | 10-K 2026-02-19 · proof | |
| Total assets | $2.9 billion | $1.7 billion | +70% | 10-K 2026-02-19 · proof |
| Total liabilities | $3.1 billion | $2.8 billion | +10.7% | 10-K 2026-02-19 · proof |
| Cash and cash equivalents | $984.6 million | $779.7 million | +26.3% | 10-K 2026-02-19 · proof |
- What was PTC THERAPEUTICS, INC. (PTCT)'s revenue in fiscal 2025?
- PTC THERAPEUTICS, INC. (PTCT) reported revenue of $1.7 billion for fiscal 2025 (the year ended Dec 31, 2025), against $806.8 million the year before (+114.5%). Source: the 10-K filed with the SEC on Feb 19, 2026. SEC
- What was PTC THERAPEUTICS, INC. (PTCT)'s operating income in fiscal 2025?
- PTC THERAPEUTICS, INC. (PTCT) reported operating income of $866.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$302.6 million the year before. Source: the 10-K filed with the SEC on Feb 19, 2026. SEC
- What was PTC THERAPEUTICS, INC. (PTCT)'s net income in fiscal 2025?
- PTC THERAPEUTICS, INC. (PTCT) reported net income of $682.6 million for fiscal 2025 (the year ended Dec 31, 2025), against -$363.3 million the year before. Source: the 10-K filed with the SEC on Feb 19, 2026. SEC
- What was PTC THERAPEUTICS, INC. (PTCT)'s cash from operating activities in fiscal 2025?
- PTC THERAPEUTICS, INC. (PTCT) reported cash from operating activities of $711.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$107.7 million the year before. Source: the 10-K filed with the SEC on Feb 19, 2026. SEC
- What was PTC THERAPEUTICS, INC. (PTCT)'s free cash flow in fiscal 2025?
- PTC THERAPEUTICS, INC. (PTCT) reported free cash flow of $702.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$114.2 million the year before. Source: the 10-K filed with the SEC on Feb 19, 2026. SEC
- What are PTC THERAPEUTICS, INC. (PTCT)'s total assets?
- As of Dec 31, 2025, PTC THERAPEUTICS, INC. (PTCT) reported total assets of $2.9 billion, against $1.7 billion a year earlier (+70%). Source: the 10-K filed with the SEC on Feb 19, 2026. SEC
- What are PTC THERAPEUTICS, INC. (PTCT)'s total liabilities?
- As of Dec 31, 2025, PTC THERAPEUTICS, INC. (PTCT) reported total liabilities of $3.1 billion, against $2.8 billion a year earlier (+10.7%). Source: the 10-K filed with the SEC on Feb 19, 2026. SEC
- What are PTC THERAPEUTICS, INC. (PTCT)'s cash and cash equivalents?
- As of Dec 31, 2025, PTC THERAPEUTICS, INC. (PTCT) reported cash and cash equivalents of $984.6 million, against $779.7 million a year earlier (+26.3%). Source: the 10-K filed with the SEC on Feb 19, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:PTCT&period_type=annual&limit=5"Information only, not investment advice.